Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Regenerative Medical Technology (RMTG) Other Non-Current Liabilities (2021 - 2025)

Historic Other Non-Current Liabilities for Regenerative Medical Technology (RMTG) over the last 5 years, with Q3 2025 value amounting to $7029.0.

  • Regenerative Medical Technology's Other Non-Current Liabilities rose 2610.33% to $7029.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $7029.0, marking a year-over-year increase of 2610.33%. This contributed to the annual value of $4689.0 for FY2024, which is 11849.95% up from last year.
  • As of Q3 2025, Regenerative Medical Technology's Other Non-Current Liabilities stood at $7029.0, which was up 2610.33% from $6166.0 recorded in Q2 2025.
  • Regenerative Medical Technology's Other Non-Current Liabilities' 5-year high stood at $20442.0 during Q4 2021, with a 5-year trough of $2146.0 in Q4 2023.
  • Over the past 5 years, Regenerative Medical Technology's median Other Non-Current Liabilities value was $5706.0 (recorded in 2024), while the average stood at $7129.6.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first plummeted by 6932.73% in 2023, then surged by 11849.95% in 2024.
  • Over the past 5 years, Regenerative Medical Technology's Other Non-Current Liabilities (Quarter) stood at $20442.0 in 2021, then tumbled by 66.03% to $6944.0 in 2022, then tumbled by 69.1% to $2146.0 in 2023, then soared by 118.5% to $4689.0 in 2024, then surged by 49.9% to $7029.0 in 2025.
  • Its Other Non-Current Liabilities was $7029.0 in Q3 2025, compared to $6166.0 in Q2 2025 and $5838.0 in Q1 2025.